We are live on ! Find out more
CNTA

Centessa Pharmaceuticals
CNTA

Delisted

CNTA was delisted on the 23rd of June, 2026.

Back to rankings

117 hedge funds and large institutions have $1.62B invested in Centessa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more call options, than puts

Call options by funds: $8.54M | Put options by funds: $2.02M

32% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 34

1.27% less ownership

Funds ownership: 93.79% → 92.52% (-1.3%)

9% less funds holding

Funds holding: 129 → 117 (-12)

10% less capital invested

Capital invested by funds: $1.8B → $1.62B (-$174M)

29% less funds holding in top 10

Funds holding in top 10: 14 → 10 (-4)

39% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 31

Holders
117
Holders Change
-12
Holders Change %
-9.3%
% of All Funds
1.54%
Holding in Top 10
10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
19
Increased
45
Reduced
34
Closed
31
Calls
$8.54M
Puts
$2.02M
Net Calls
+$6.52M
Net Calls Change
+$15.9M

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$18.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$18.4M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$15.5M
4
Millennium Management
Millennium Management
New York
+$13.3M
5
PCH
Polar Capital Holdings
United Kingdom
+$12.7M

Top Sellers

Rank Fund Capital Flow
1
Holocene Advisors
Holocene Advisors
New York
-$32.4M
2
PA
Perceptive Advisors
New York
-$24M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$22.2M
4
BBA
Baker Bros. Advisors
New York
-$17.6M
5
Morgan Stanley
Morgan Stanley
New York
-$14.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
MVM
1
Medicxi Ventures Management
Jersey
$262M – – –
IVLAV
2
Index Venture Life Associates VI
Jersey
$131M – – –
GA
3
General Atlantic
New York
$127M – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$110M +$18.4M +1,449,000 +21%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$85.8M +$7.73M +610,282 +10%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$77.6M +$7.17M +565,648 +11%
ACA
7
Avoro Capital Advisors
New York
$65.7M +$12M +950,000 +23%
FCM
8
Farallon Capital Management
California
$59.5M +$2.47M +195,000 +4%
FLAM
9
First Light Asset Management
Minnesota
$56.4M -$7.36M -580,713 -12%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$50.3M – – –
SL
11
Siren LLC
Connecticut
$45.5M +$6.33M +500,000 +17%
CC
12
Commodore Capital
New York
$43.3M +$11.8M +930,711 +39%
TCM
13
TCG Crossover Management
California
$38M – – –
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$34.1M +$3.87M +305,163 +13%
Franklin Resources
15
Franklin Resources
California
$33.4M +$19.5K +1,540 +0.1%
CAM
16
Cormorant Asset Management
Massachusetts
$27.4M -$2.22M -175,000 -8%
Morgan Stanley
17
Morgan Stanley
New York
$23.6M -$14.5M -1,143,996 -39%
Millennium Management
18
Millennium Management
New York
$21.8M +$13.3M +1,048,699 +172%
RI
19
RTW Investments
New York
$20.1M +$18.7M +1,479,836 +2,960%
SC
20
Stempoint Capital
New York
$16.6M +$8.52M +672,337 +113%
FCMV
21
Foresite Capital Management VI
California
$16.5M – – –
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
$16.1M +$15.5M +1,221,610 New
PA
23
Perceptive Advisors
New York
$15.1M -$24M -1,893,460 -62%
American Century Companies
24
American Century Companies
Missouri
$14.9M +$481K +37,954 +3%
OCA
25
Octagon Capital Advisors
New York
$13.5M -$5M -395,000 -28%
1
2 3 4 5

CNTA Hedge Fund Activity: Q2 2025 in Review

117 of the 7,601 institutional investors tracked by Wall St. Rank reported a position in Centessa Pharmaceuticals (CNTA) for Q2 2025, worth a combined $1.62B — down 9.7% from $1.8B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of CNTA and 19 opened new positions — a net loss of 12 holders — while 34 trimmed existing stakes and 45 added.

The largest buyer was RTW Investments, adding an estimated $18.7M. The largest seller was Holocene Advisors, exiting entirely with an estimated $32.4M sold.

  • 117 institutional investors held Centessa Pharmaceuticals (CNTA) as of Q2 2025, down from 129 in Q1 2025.
  • Funds reported $1.62B of Centessa Pharmaceuticals stock for Q2 2025, down 9.7% quarter-over-quarter.
  • 19 funds opened new Centessa Pharmaceuticals positions in Q2 2025 and 31 closed out, a net change of -12 holders.
  • The largest Centessa Pharmaceuticals buyer in Q2 2025 was RTW Investments, an estimated $18.7M added.
  • The largest Centessa Pharmaceuticals seller in Q2 2025 was Holocene Advisors, an estimated $32.4M sold.

Based on aggregated 13F filings for Q2 2025.